Can a 30-hour e-learning course equip family doctors to deliver better palliative care?

NCT ID NCT07737899

First seen Jul 30, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This trial explores whether a training program for general practitioners can improve how primary care clinics deliver palliative care to adults with advanced cancer, COPD, heart failure, or kidney disease. One family health unit will use the new approach—a 30-hour e-learning course plus a structured four-visit consultation model—while another continues usual care. The study focuses on whether doctors and patients can successfully follow the program, setting the stage for a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a two-component complex intervention: a 30-hour e-learning training program for general practitioners plus a structured consultation model (4 consultations over 12 weeks)
What this could lead to
If successful, this could pave the way for a larger trial testing whether GP training improves palliative care for people with advanced chronic diseases.
What could go wrong
This is a small feasibility study with only two family health units, so results may not apply broadly. The intervention requires significant GP time and commitment, which could limit real-world uptake.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Family Health Unit 1 - ULS Coimbra (Intervention)

    Coimbra, Portugal

  • Family Health Unit 2 - ULS Coimbra (Control)

    Coimbra, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.